Drug Related Problems Associated HospitalizationsNCT01223950
Monitoring the Prevalence of E.R Admissions and Hospitalizations as a Result of Drug Related Problems (DRPs)
An observational study of Drug Related Problems Associated Hospitalizations, run by Hillel Yaffe Medical Center.
Trial summary
To research the prevalence and nature of DRP (Drug Related Problems) associated hospitalizations (hospitalizations due to problems\adverse effects of the medication treatment) . Analyzing the main reasons for DRP associated E.R admissions\hospitalizations. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Drug Related Problems Associated Hospitalizations
- How many people
- 12,350 participants
- Where
- No sites listed yet
- Study dates
- Aug 2010to Sep 2010
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: 18 years of age and above) admitted to the E.R and subsequently to hospital wards of the Hillel Yaffe medical center, Hadera, Israel.
Who may be able to join
- Possible DRP based on the current literature, patient questionnaire and drug history, related laboratories test values, ICD-9 coding.
Who cannot join
- DRP cannot be established or suspected based on the assessment of the patient's lab results, symptoms, drug treatment and patient's questioning as well as physician diagnosis
About this study
To research the prevalence and nature of DRP (Drug Related Problems) associated hospitalizations (hospitalizations due to problems\adverse effects of the medication treatment) .
Analyzing the main reasons for DRP associated E.R admissions\hospitalizations. identifying drug involved and percentage of DRP associated hospitalizations.
Monitoring the length of DRP associated hospitalizations. Evaluating LOS to hospitalized. Financial and other aspects will be measured.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Oct 2010 (estimated)
- Study startAug 2010
- Primary completionSep 2010
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (9)Papers the sponsor has linked to this study.
- Other trials for Drug Related Problems Associated HospitalizationsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 12,350 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hillel Yaffe Medical Center
- Sponsor type
- Other government
- Collaborators
- Ben-Gurion University of the Negev
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01223950
- Sponsor's protocol ID
- 0067-10-HYMC
- Status last verified
- Oct 2010
- First submitted
- 18 Oct 2010
- Last updated
- 19 Oct 2010
- Results posted
- No
- Data monitoring committee
- No
Publications
Doggrell SA. Adherence to medicines in the older-aged with chronic conditions: does intervention by an allied health professional help? Drugs Aging. 2010 Mar 1;27(3):239-54. doi: 10.2165/11532870-000000000-00000.
PubMed 20210369Sotoca Momblona JM, Canivell Fuste S, Alemany Vilches L, Siso Almirall A, Codina Jane C, Ribas Sala J. [Drug related problems and hospital admissions]. Aten Primaria. 2009 Mar;41(3):141-6. doi: 10.1016/j.aprim.2008.07.002. Epub 2009 Apr 8. Spanish.
PubMed 19356826Rogers S, Wilson D, Wan S, Griffin M, Rai G, Farrell J. Medication-related admissions in older people: a cross-sectional, observational study. Drugs Aging. 2009;26(11):951-61. doi: 10.2165/11316750-000000000-00000.
PubMed 19848440Al-Olah YH, Al Thiab KM. Admissions through the emergency department due to drug-related problems. Ann Saudi Med. 2008 Nov-Dec;28(6):426-9. doi: 10.5144/0256-4947.2008.426.
PubMed 19011316Howard R, Avery A, Bissell P. Causes of preventable drug-related hospital admissions: a qualitative study. Qual Saf Health Care. 2008 Apr;17(2):109-16. doi: 10.1136/qshc.2007.022681.
PubMed 18385404Blix HS, Viktil KK, Moger TA, Reikvam A. Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams. Pharm World Sci. 2006 Jun;28(3):152-8. doi: 10.1007/s11096-006-9020-z. Epub 2006 Sep 27.
PubMed 17004023Koh Y, Fatimah BM, Li SC. Therapy related hospital admission in patients on polypharmacy in Singapore: a pilot study. Pharm World Sci. 2003 Aug;25(4):135-7. doi: 10.1023/a:1024896328720.
PubMed 12964490Patel P, Zed PJ. Drug-related visits to the emergency department: how big is the problem? Pharmacotherapy. 2002 Jul;22(7):915-23. doi: 10.1592/phco.22.11.915.33630.
PubMed 12126224Klein C, Prokhorov T, Miniovitz A, Dobronevsky E, Rabey JM. Admission of Parkinsonian patients to a neurological ward in a community hospital. J Neural Transm (Vienna). 2009 Nov;116(11):1509-12. doi: 10.1007/s00702-009-0302-1.
PubMed 19763774
Study at a glance
From the registry record, last updated by the sponsor on 19 Oct 2010. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Monitoring the Prevalence of E.R Admissions and Hospitalizations as a Result of Drug Related Problems (DRPs)
- ClinicalTrials.gov ID
- NCT01223950
- Acronym / sponsor ID
- 0067-10-HYMC
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 12,350 participants (actual)
- Lead sponsor
- Hillel Yaffe Medical CenterOther government
- Collaborators
- Ben-Gurion University of the Negev
- Study start
- Aug 2010
- Primary completion
- Sep 2010 (actual)
- First posted
- 19 Oct 2010 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To research the prevalence and nature of DRP (Drug Related Problems) associated hospitalizations (hospitalizations due to problems\adverse effects of the medication treatment) .
Analyzing the main reasons for DRP associated E.R admissions\hospitalizations. identifying drug involved and percentage of DRP associated hospitalizations.
Monitoring the length of DRP associated hospitalizations. Evaluating LOS to hospitalized. Financial and other aspects will be measured.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- 18 years of age and above) admitted to the E.R and subsequently to hospital wards of the Hillel Yaffe medical center, Hadera, Israel.
Key inclusion criteria (1 listed)
- Possible DRP based on the current literature, patient questionnaire and drug history, related laboratories test values, ICD-9 coding.
Key exclusion criteria (1 listed)
- DRP cannot be established or suspected based on the assessment of the patient's lab results, symptoms, drug treatment and patient's questioning as well as physician diagnosis
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Oct 2010.
- Background: PubMed 20210369Doggrell SA. Adherence to medicines in the older-aged with chronic conditions: does intervention by an allied health professional help? Drugs Aging. 2010 Mar 1;27(3):239-54. doi: 10.2165/11532870-000000000-00000.
- Background: PubMed 19356826Sotoca Momblona JM, Canivell Fuste S, Alemany Vilches L, Siso Almirall A, Codina Jane C, Ribas Sala J. [Drug related problems and hospital admissions]. Aten Primaria. 2009 Mar;41(3):141-6. doi: 10.1016/j.aprim.2008.07.002. Epub 2009 Apr 8. Spanish.
- Background: PubMed 19848440Rogers S, Wilson D, Wan S, Griffin M, Rai G, Farrell J. Medication-related admissions in older people: a cross-sectional, observational study. Drugs Aging. 2009;26(11):951-61. doi: 10.2165/11316750-000000000-00000.
- Background: PubMed 19011316Al-Olah YH, Al Thiab KM. Admissions through the emergency department due to drug-related problems. Ann Saudi Med. 2008 Nov-Dec;28(6):426-9. doi: 10.5144/0256-4947.2008.426.
- Background: PubMed 18385404Howard R, Avery A, Bissell P. Causes of preventable drug-related hospital admissions: a qualitative study. Qual Saf Health Care. 2008 Apr;17(2):109-16. doi: 10.1136/qshc.2007.022681.
- Background: PubMed 17004023Blix HS, Viktil KK, Moger TA, Reikvam A. Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams. Pharm World Sci. 2006 Jun;28(3):152-8. doi: 10.1007/s11096-006-9020-z. Epub 2006 Sep 27.
- Background: PubMed 12964490Koh Y, Fatimah BM, Li SC. Therapy related hospital admission in patients on polypharmacy in Singapore: a pilot study. Pharm World Sci. 2003 Aug;25(4):135-7. doi: 10.1023/a:1024896328720.
- Background: PubMed 12126224Patel P, Zed PJ. Drug-related visits to the emergency department: how big is the problem? Pharmacotherapy. 2002 Jul;22(7):915-23. doi: 10.1592/phco.22.11.915.33630.
- Background: PubMed 19763774Klein C, Prokhorov T, Miniovitz A, Dobronevsky E, Rabey JM. Admission of Parkinsonian patients to a neurological ward in a community hospital. J Neural Transm (Vienna). 2009 Nov;116(11):1509-12. doi: 10.1007/s00702-009-0302-1.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Drug Related Problems Associated Hospitalizations, run by Hillel Yaffe Medical Center.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Oct 2010. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01223950, which also lists 9 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Oct 2010.